The safety of vedolizumab for ulcerative colitis and Crohn's disease.

Abstract:

OBJECTIVE:Vedolizumab is a gut-selective antibody to α4β7 integrin for the treatment of ulcerative colitis (UC) and Crohn's disease (CD). We report an integrated summary of the safety of vedolizumab. DESIGN:Safety data (May 2009-June 2013) from six trials of vedolizumab were integrated. Adverse events were evaluated in patients who received ≥1 dose of vedolizumab or placebo and were reported as exposure-adjusted incidence rates as the number of patients experiencing the event per 100 person-years (PYs) of exposure. Predictors of serious infection were assessed using a Cox proportional hazards model. RESULTS:In total, 2830 patients had 4811 PYs of vedolizumab exposure (median exposure range, 1-1977 days). No increased risk of any infection or serious infection was associated with vedolizumab exposure. Serious clostridial infections, sepsis and tuberculosis were reported infrequently (≤0.6% of patients). No cases of progressive multifocal leucoencephalopathy were observed. Independent risk factors for serious infection in UC were prior failure of a tumour necrosis factor α antagonist (HR, 1.99; 95% CIs 1.16 to 3.42; p=0.0122) and narcotic analgesic use (HR, 2.68; 95% CI 1.57 to 4.58; p=0.0003), and in CD were younger age (HR, 0.97; 95% CI 0.95 to 0.98; p<0.0001), corticosteroid (HR, 1.88; 95% CI 1.35 to 2.63; p=0.0002) or narcotic analgesic use (HR, 2.72; 95% CI 1.90 to 3.89; p<0.0001). Investigator-defined infusion-related reactions were reported for ≤5% of patients in each study. Eighteen vedolizumab-exposed patients (<1%) were diagnosed with a malignancy. CONCLUSIONS:Vedolizumab has a favourable safety profile with low incidence rates of serious infections, infusion-related reactions and malignancies over an extended treatment period. TRIAL REGISTRATION NUMBER:NCT01177228, NCT00619489, NCT00783718, NCT00783692, NCT01224171, NCT00790933.

journal_name

Gut

journal_title

Gut

authors

Colombel JF,Sands BE,Rutgeerts P,Sandborn W,Danese S,D'Haens G,Panaccione R,Loftus EV Jr,Sankoh S,Fox I,Parikh A,Milch C,Abhyankar B,Feagan BG

doi

10.1136/gutjnl-2015-311079

subject

Has Abstract

pub_date

2017-05-01 00:00:00

pages

839-851

issue

5

eissn

0017-5749

issn

1468-3288

pii

gutjnl-2015-311079

journal_volume

66

pub_type

杂志文章

相关文献

GUT文献大全
  • Abnormal lactic dehydrogenase isoenzyme patterns in ulcerative colitis with precancerous change.

    abstract::The isoenzyme pattern of lactic dehydrogenase was measured in rectal biopsies from six patients with ulcerative colitis in whom precancerous histological changes had been independently recognized. There was a highly significant increase in the ratio of isoenzymes IV + V to I + II. This suggests that lactic dehydrogena...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gut.12.1.16

    authors: Lewis B,Morson BC,February AW,Jones JH,Misiewicz JJ

    更新日期:1971-01-01 00:00:00

  • Personalised surveillance for serrated polyposis syndrome: results from a prospective 5-year international cohort study.

    abstract:BACKGROUND AND AIMS:Serrated polyposis syndrome (SPS) is associated with an increased risk of colorectal cancer (CRC). International guidelines recommend surveillance intervals of 1-2 years. However, yearly surveillance likely leads to overtreatment for many. We prospectively assessed a surveillance protocol aiming to ...

    journal_title:Gut

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1136/gutjnl-2018-318134

    authors: Bleijenberg AG,IJspeert JE,van Herwaarden YJ,Carballal S,Pellisé M,Jung G,Bisseling TM,Nagtegaal ID,van Leerdam ME,van Lelyveld N,Bessa X,Rodríguez-Moranta F,Bastiaansen B,de Klaver W,Rivero L,Spaander MC,Koornstra JJ,B

    更新日期:2020-01-01 00:00:00

  • CDP571, a humanised monoclonal antibody to tumour necrosis factor alpha, for moderate to severe Crohn's disease: a randomised, double blind, placebo controlled trial.

    abstract:BACKGROUND:Targeting tumour necrosis factor alpha (TNF-alpha) has demonstrated efficacy in Crohn's disease. AIM:To evaluate CDP571, a humanised antibody to TNF-alpha, for treating active Crohn's disease. PATIENTS:A total of 396 patients with moderate to severe Crohn's disease. METHODS:In a 28 week, randomised, doubl...

    journal_title:Gut

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1136/gut.2003.035253

    authors: Sandborn WJ,Feagan BG,Radford-Smith G,Kovacs A,Enns R,Innes A,Patel J

    更新日期:2004-10-01 00:00:00

  • A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma.

    abstract:OBJECTIVE:Hepatocellular carcinoma (HCC) is a heterogeneous tumour displaying a complex variety of genetic and epigenetic changes. In human cancers, aberrant post-transcriptional modifications, such as alternative splicing and RNA editing, may lead to tumour specific transcriptome diversity. DESIGN:By utilising large ...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gutjnl-2012-304037

    authors: Chan TH,Lin CH,Qi L,Fei J,Li Y,Yong KJ,Liu M,Song Y,Chow RK,Ng VH,Yuan YF,Tenen DG,Guan XY,Chen L

    更新日期:2014-05-01 00:00:00

  • Immunohistochemical changes in the jejunum in first degree relatives of patients with coeliac disease and the coeliac disease marker DQ genes. HLA class II antigen expression, interleukin-2 receptor positive cells and dividing crypt cells.

    abstract::The staining of HLA class II antigens, the presence of cells positive for interleukin-2 receptors, the proportion of crypt cells in mitosis in the jejunal biopsy specimens, and the dose of coeliac disease marker HLA-DQ genes were studied in 75 healthy family members of coeliac disease patients. Eleven had silent coeli...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gut.35.1.55

    authors: Holm K,Savilahti E,Koskimies S,Lipsanen V,Mäki M

    更新日期:1994-01-01 00:00:00

  • Race-dependent association of sulfidogenic bacteria with colorectal cancer.

    abstract:OBJECTIVE:Colorectal cancer (CRC) incidence is higher in African Americans (AAs) compared with non-Hispanic whites (NHWs). A diet high in animal protein and fat is an environmental risk factor for CRC development. The intestinal microbiota is postulated to modulate the effects of diet in promoting or preventing CRC. Hy...

    journal_title:Gut

    pub_type: 杂志文章,多中心研究

    doi:10.1136/gutjnl-2016-313321

    authors: Yazici C,Wolf PG,Kim H,Cross TL,Vermillion K,Carroll T,Augustus GJ,Mutlu E,Tussing-Humphreys L,Braunschweig C,Xicola RM,Jung B,Llor X,Ellis NA,Gaskins HR

    更新日期:2017-11-01 00:00:00

  • Potentiation of TRPV4 signalling by histamine and serotonin: an important mechanism for visceral hypersensitivity.

    abstract:BACKGROUND:Although evidence points to a role for histamine and serotonin in visceral hypersensitivity, activation of calcium channels such as transient receptor potential vanilloid 4 (TRPV4) also causes visceral hypersensitivity. We hypothesised that TRPV4 is important for the generation of hypersensitivity, mediating...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gut.2009.192567

    authors: Cenac N,Altier C,Motta JP,d'Aldebert E,Galeano S,Zamponi GW,Vergnolle N

    更新日期:2010-04-01 00:00:00

  • Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial.

    abstract:OBJECTIVE:Eosinophilic oesophagitis (EoO) is a clinicopathological condition defined by proton pump inhibitor-refractory oesophageal symptoms combined with oesophageal eosinophilia. The pharmacodynamic effect of mepolizumab (a humanised anti-interleukin-5 monoclonal antibody) in EoO was evaluated. METHODS:Eleven adult...

    journal_title:Gut

    pub_type: 杂志文章,随机对照试验

    doi:10.1136/gut.2009.178558

    authors: Straumann A,Conus S,Grzonka P,Kita H,Kephart G,Bussmann C,Beglinger C,Smith DA,Patel J,Byrne M,Simon HU

    更新日期:2010-01-01 00:00:00

  • Biliary lipid output during three meals and an overnight fast. II. Effect of chenodeoxycholic acid treatment in gallstone subjects.

    abstract::Oral treatment with chenodeoxycholic acid causes dissolution of cholesterol gallstones in man. In order to determine the mechanism of this effect, we have measured 24-hour biliary lipid output, lipid composition of fasting gallbladder bile, and bile acid pool sizes before and during such treatment in six patients with...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gut.16.1.12

    authors: Northfield TC,LaRusso NF,Hofmann AF,Thistle JL

    更新日期:1975-01-01 00:00:00

  • A case of 'Crohn's carcinoma'.

    abstract::A case of adenocarcinoma of the ileum, occurring in an area concomitantly the site of Crohn's disease, is described. Examination of the literature suggests that there are certain characteristics of the small bowel carcinoma which arises in Crohn's disease. These include invisibility of the tumour on macroscopic inspec...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gut.16.7.533

    authors: Fleming KA,Pollock AC

    更新日期:1975-07-01 00:00:00

  • Liver damage associated with perhexiline maleate.

    abstract::Two patients who developed biochemical and histological evidence of hepatitis while taking the anti-anginal drug perhexiline maleate are described. The pathological changes were those of mild to moderate fatty change together with a hepatitis which resembled alcoholic hepatitis, including in one patient the presence o...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gut.20.3.186

    authors: Lewis D,Wainwright HC,Kew MC,Zwi S,Isaacson C

    更新日期:1979-03-01 00:00:00

  • Controlled study of autoimmunization against liver in inbred rat strains.

    abstract::By prolonged immunization of an inbred rat strain with isologous liver homogenate in Freund's complete adjuvant a low grade autoimmune ;cholangitis' with periductular fibrosis has been demonstrated. The lesion could be transferred to isogeneic animals by serial spleen cell injections and was associated with mild but v...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gut.12.6.458

    authors: Maclaurin BP

    更新日期:1971-06-01 00:00:00

  • Gastric mucosal hyperplasia via upregulation of gastrin induced by persistent activation of gastric innate immunity in major histocompatibility complex class II deficient mice.

    abstract:BACKGROUND AND AIMS:Major histocompatibility complex class II deficient (Aalpha0/0) mice have decreased CD4+ T cells, making them immunologically similar to patients with acquired immunodeficiency syndrome (AIDS). Both patients with AIDS and Aalpha0/0 mice have hypertrophic gastric folds. To clarify the mechanism of ga...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gut.2005.077917

    authors: Fukui T,Nishio A,Okazaki K,Uza N,Ueno S,Kido M,Inoue S,Kitamura H,Kiriya K,Ohashi S,Asada M,Tamaki H,Matsuura M,Kawasaki K,Suzuki K,Uchida K,Fukui H,Nakase H,Watanabe N,Chiba T

    更新日期:2006-05-01 00:00:00

  • Studies on the effect of vagotomy on small intestinal motility using the radiotelemetering capsule.

    abstract::The radio-telemetering capsule (radio-pill) has been used to study the return of motility in the small bowel after vagotomy with a drainage procedure, gastric operations not involving vagotomy, and non-gastric operations. Small intestinal movements returned in about 10 hours after vagotomy, about four hours after the ...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gut.4.1.77

    authors: ROSS B,WATSON BW,KAY AW

    更新日期:1963-03-01 00:00:00

  • Detection of subclinical autonomic neuropathy in constipated patients using a sweat test.

    abstract::Chronic idiopathic constipation may be the result of an autonomic neuropathy. This hypothesis was tested in 23 constipated patients and 17 age matched controls, using the acetylcholine sweat spot test devised to test autonomic integrity in diabetes. Acetylcholine (0.01%) was injected in the dorsum of the foot painted ...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gut.33.11.1539

    authors: Altomare D,Pilot MA,Scott M,Williams N,Rubino M,Ilincic L,Waldron D

    更新日期:1992-11-01 00:00:00

  • Coeliac disease: characterisation of monoclonal antibodies raised against a synthetic peptide corresponding to amino acid residues 206-217 of A-gliadin.

    abstract::A dodecapeptide of A-gliadin, which shares amino acid homologies with the E1b protein of adenovirus 12, was used to produce murine monoclonal antibodies. Five monoclonal antibodies were produced and were screened by enzyme linked immunosorbant assay, immunodot assay, and immunoblotting. The antibodies were tested agai...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gut.33.11.1504

    authors: Ellis HJ,Doyle AP,Sturgess RP,Ciclitira PJ

    更新日期:1992-11-01 00:00:00

  • Translocation of gliadin into HLA-DR antigen containing lysosomes in coeliac disease enterocytes.

    abstract::Coeliac disease is triggered by ingestion of wheat gliadin and is probably immune mediated. There is evidence by light microscopy that expression of class II major histocompatibility complex (MHC) molecules is increased in the small intestinal epithelium of patients with untreated coeliac disease and that gliadin can ...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gut.36.5.703

    authors: Zimmer KP,Poremba C,Weber P,Ciclitira PJ,Harms E

    更新日期:1995-05-01 00:00:00

  • Motor activity recorded in the unprepared colon of healthy humans.

    abstract::A manometric method was developed to study the motor activity in the unprepared human colon, and the results in eight healthy subjects were compared with those obtained in the same subjects after bowel cleansing with a non-absorbable solution containing polyethylene glycol 4000 (PEG). A tube assembly (4.5 m long, 12 l...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gut.37.5.649

    authors: Lémann M,Flourié B,Picon L,Coffin B,Jian R,Rambaud JC

    更新日期:1995-11-01 00:00:00

  • Blocking VCAM-1 inhibits pancreatic tumour progression and cancer-associated thrombosis/thromboembolism.

    abstract:OBJECTIVE:Pancreatic ductal adenocarcinoma (PDAC) is the deadliest cancer. Cancer-associated thrombosis/thromboembolism (CAT), frequently observed in PDAC, is known as a poor prognostic factor. Here, we investigated the underlying mechanisms between PDAC and CAT, and performed a trial of therapeutic approach for PDAC u...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gutjnl-2020-320608

    authors: Sano M,Takahashi R,Ijichi H,Ishigaki K,Yamada T,Miyabayashi K,Kimura G,Mizuno S,Kato H,Fujiwara H,Nakatsuka T,Tanaka Y,Kim J,Masugi Y,Morishita Y,Tanaka M,Ushiku T,Nakai Y,Tateishi K,Ishii Y,Isayama H,Moses HL,

    更新日期:2020-10-21 00:00:00

  • Development of chronic hepatocerebral degeneration eight years after a distal splenorenal (Warren) shunt.

    abstract::It is well known that chronic encephalopathy may be a major complication after the establishment of a surgical portal caval shunt for an episode of variceal haemorrhage. In an effort to minimise this problem Warren and colleagues developed the distal splenorenal shunt where the portal and mesenteric blood flow to the ...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gut.30.10.1419

    authors: Bleasel AF,Waugh RC,McCaughan GW

    更新日期:1989-10-01 00:00:00

  • Pathophysiological role of secretory type I and II phospholipase A2 in acute pancreatitis: an experimental study in rats.

    abstract:BACKGROUND:In human acute pancreatitis two different types of secretory phospholipase A2 (PLA2) have been found. AIM:To analyse the specific pattern of distribution of these PLA2 activities and their pathophysiological role in experimental acute pancreatitis. SUBJECTS AND METHODS:Catalytic activities of secretory typ...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gut.40.3.386

    authors: Uhl W,Schrag HJ,Schmitter N,Nevalainen TJ,Aufenanger J,Wheatley AM,Büchler MW

    更新日期:1997-03-01 00:00:00

  • Definitions of reflux disease and its separation from dyspepsia.

    abstract::Management strategies for reflux disease are very different from those for dyspepsia and so differentiating between patients with "true" dyspepsia and those whose primary symptom is heartburn is a key step in their management. This separation has become more clear during the last decade as insights into reflux disease...

    journal_title:Gut

    pub_type: 杂志文章,评审

    doi:10.1136/gut.50.suppl_4.iv17

    authors: Dent J

    更新日期:2002-05-01 00:00:00

  • Consequences of partial and subtotal colectomy in the rat.

    abstract::Rats were subjects to right hemicolectomy (including removal of the caecum), left hemicolectomy or subtotal colectomy. Body weight resumed and maintained a rate of increase very similar to that in control rats. After hemicolectomy, food intake showed no change. Faecal weight increased by about one-third after right he...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gut.18.1.37

    authors: Masesa PC,Forrester JM

    更新日期:1977-01-01 00:00:00

  • Interpretation of the breath hydrogen profile obtained after ingesting a solid meal containing unabsorbable carbohydrate.

    abstract::The extent to which monitoring breath hydrogen excretion provides information concerning the entry of the residues of a solid test meal into the colon was investigated in 89 normal subjects, and 11 patients with the irritable bowel syndrome. The profile of breath hydrogen concentration showed an early peak, that occur...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gut.26.8.834

    authors: Read NW,Al-Janabi MN,Bates TE,Holgate AM,Cann PA,Kinsman RI,McFarlane A,Brown C

    更新日期:1985-08-01 00:00:00

  • Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis.

    abstract:BACKGROUND AND AIMS:Colonoscopic surveillance for cancer in longstanding extensive ulcerative colitis relies heavily on non-targeted mucosal biopsies. Chromoendoscopy can aid detection of subtle mucosal abnormalities. We hypothesised that routine pancolonic indigo carmine dye spraying would improve the macroscopic dete...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gut.2003.016386

    authors: Rutter MD,Saunders BP,Schofield G,Forbes A,Price AB,Talbot IC

    更新日期:2004-02-01 00:00:00

  • Antibody (IgG, IgA, and IgM) to baker's yeast (Saccharomyces cerevisiae), yeast mannan, gliadin, ovalbumin and betalactoglobulin in monozygotic twins with inflammatory bowel disease.

    abstract::To assess whether dietary antigens play a role in inflammatory bowel disease, 26 monozygotic twin pairs with inflammatory bowel disease and 52 healthy controls were investigated for serum antibodies (IgA, IgG, IgM) against ovalbumin, betalactoglobulin, gliadin, whole yeast (Saccharomyces cerevisiae) and yeast cell wal...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gut.33.7.909

    authors: Lindberg E,Magnusson KE,Tysk C,Järnerot G

    更新日期:1992-07-01 00:00:00

  • Radiographic evaluation of pancreatico-jejunal shunts.

    abstract::This paper describes opacification and identification of two surgically constructed pancreatico-jujunal shunts. A fibreoptic panendoscope was used with retrograde injection via the ampulla of Vater (ERCP). This procedure makes possible more accurate anatomical evaluation and so more precise clinical appraisal of both...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gut.17.6.439

    authors: Miller EW,Goldberg HI,Goldberg SB,Shapiro H

    更新日期:1976-06-01 00:00:00

  • Metabolic surgery profoundly influences gut microbial-host metabolic cross-talk.

    abstract:BACKGROUND AND AIMS:Bariatric surgery is increasingly performed worldwide to treat morbid obesity and is also known as metabolic surgery to reflect its beneficial metabolic effects especially with respect to improvement in type 2 diabetes. Understanding surgical weight loss mechanisms and metabolic modulation is requir...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gut.2010.234708

    authors: Li JV,Ashrafian H,Bueter M,Kinross J,Sands C,le Roux CW,Bloom SR,Darzi A,Athanasiou T,Marchesi JR,Nicholson JK,Holmes E

    更新日期:2011-09-01 00:00:00

  • Highly bioavailable silibinin nanoparticles inhibit HCV infection.

    abstract:OBJECTIVE:Silibinin is a flavonolignan that is well established for its robust antiviral activity against HCV infection and has undergone several clinical trials for the management of hepatitis C. Despite its potency, silibinin suffers from poor solubility and bioavailability, restricting its clinical use. To overcome ...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gutjnl-2016-312019

    authors: Liu CH,Lin CC,Hsu WC,Chung CY,Lin CC,Jassey A,Chang SP,Tai CJ,Tai CJ,Shields J,Richardson CD,Yen MH,Tyrrell DLJ,Lin LT

    更新日期:2017-10-01 00:00:00

  • Biliary bile acids in cholelithiasis and colon cancer.

    abstract::The role of biliary deoxycholate as an endogenous colon carcinogen and the possible association between cholelithiasis and/or cholecystectomy and the subsequent development of large bowel cancer is unclear. This paper describes biliary bile acids analysis performed on 13 patients undergoing cholecystectomy for gall st...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gut.30.6.860

    authors: Castleden WM,Detchon P,Misso NL

    更新日期:1989-06-01 00:00:00